Clinical studies document specific benefits including retinal neuroprotection through neurotrophic factors, improved ocular blood flow enhancing nutrient delivery to photoreceptors, reduced inflammation in age-related macular degeneration, cellular repair accelerating recovery from retinal injury, and potential prevention of progressive vision loss in diabetic retinopathy
Early research and expert summaries suggest it may promote tissue regeneration by improving circulation in damaged areas
Sikiric P, Seiwerth S, Rucman R, Turkovic B, Rokotov DS, Brcic L, Sever M
A Reddit thread pointed me to the gray market: a compounding pharmacy still shipping despite new regulatory pressure
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial